phase ii study of response-adapted ultra-low dose radiotherapy for b-cell lymphoma
Published 1 year ago • 82 plays • Length 6:43Download video MP4
Download video MP3
Similar videos
-
2:25
results from a phase i/ii trial of pirtobrutinib and lv20.19 for patients with r/r lymphomas
-
1:56
updated results of phase i/ii bruin study: pirtobrutinib in covalent btk inhibitor pretreated mcl
-
2:02
phase ii animate trial investigating pet response-adapted treatment using nivolumab in r/r chl
-
3:53
standard-of-care setting results of axi-cel in r/r large b-cell lymphoma
-
3:24
treatment of bulky stage i/ii lymphoma
-
3:18
midiagnostics' complete blood count (cbc) - blood analysis for diagnosis and monitoring
-
3:52
blood volume monitoring animation - crit-line® technology
-
6:48
electrolyte analyzer ⅰ installation guide
-
1:40
results from a phase i/ii study of golcadomide in r/r follicular lymphoma
-
1:45
a phase ii study of elritercept for lower-risk mds
-
1:44
updates from the phase ii animate trial of nivolumab in r/r chl
-
6:14
horizon scan of car-t for lymphoma
-
2:30
tti-621 for hematologic malignancies: a phase i dose escalation and expansion study
-
4:04
results of phase ii trial to assess the efficacy and safety of idelalisib
-
2:54
ck0804, a cord blood-derived cellular therapy, in myelofibrosis with suboptimal ruxolitinib response
-
3:05
car-t therapy in r/r dlbcl
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
1:25
insights into a phase ii study evaluating anx005 in waiha
-
0:45
difference between quality of life & patient-reported outcomes
-
3:04
applying molecular understanding of dlbcl to management strategies
-
2:38
zuma-1 & scholar-1: comparison of outcomes in refractory dlbcl
-
2:19
insights into the phase iia mylox-1 trial: assessing efficacy of gb2064 in myelofibrosis